Grade My Investments
HomeFree Stock Grades › USNA

USANA Health Sciences, Inc. (USNA) Stock Grade

USNA · Consumer Defensive

B
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$361.1M
P/E Ratio
33.6
Revenue Growth (YoY)
+8.3%
Net Margin
1.2%
Return on Equity
2.0%
Dividend Yield
None

About USANA Health Sciences, Inc.'s fundamentals

USANA Health Sciences has a market capitalization of $361.1 million with revenue growing 8.3% year-over-year, indicating moderate top-line expansion in the household and personal products space. However, the company's profitability metrics are notably weak, with a net margin of just 1.2% and return on equity of 2.0%, suggesting operational challenges in converting sales into earnings. Trading at a P/E ratio of 33.6, the valuation appears elevated relative to the company's thin profit generation, and USANA does not currently pay a dividend.

Track USNA free — no credit card required. Live grade + monthly AI report →